3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
11
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Neoplasms
2
Adenocarcinoma
2
Pathologic Complete Response
1
Overall Survival Comparison Between the 2 Arms
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Margins of Excision
1
Lymphatic Metastasis
1
Locally Advanced Malignant Neoplasm
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
HPV-Related Squamous Cell Carcinoma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Adenosquamous
1
Breast Neoplasms
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Cisplatin
21
Radiotherapy
16
Fluorouracil
16
Paclitaxel
15
Irinotecan
8
Docetaxel
8
Neoadjuvant Therapy
6
Drug Therapy
5
tislelizumab
4
sintilimab
4
Surgical Procedures, Operative
4
Radiation
4
Oxaliplatin
4
Leucovorin
4
Esophagectomy
4
Capecitabine
4
toripalimab
3
pembrolizumab
3
TP protocol
3
Chemotherapy, Adjuvant
3
S 1 (combination)
2
Levoleucovorin
2
Injections
2
Cetuximab
2
Carboplatin
2
lenvatinib
1
irinotecan sucrosofate
1
durvalumab
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Esophageal Squamous Cell Carcinoma
×
Chemoradiotherapy
×
Clear all
NCT04328948
2025-05-22
ARMADILLO
National Cancer Center, Japan
Phase 3
Recruiting
280 enrolled